<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/28708/ideal-patient-to-receive-alimata-plus-keytruda-keynote-189?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Ideal Patient to Receive Alimata Plus Keytruda: KEYNOTE-189

Name: Ideal Patient to Receive Alimata Plus Keytruda: KEYNOTE-189
Uploaded: 2019-07-01T09:25:09
Duration: 1 min 17 s
Description: Ravi Salgia, MD, Professor and Chair, Department of Medical Oncology and Therapeutics Research, Associate Director for Clinical Sciences, Arthur and Rosalie Kaplan Endowed Chair in Medical Oncology, City of Hope explains the ideal patient to receive Alimta plus Keytrude based on data and results from KEYNOTE-189.

00:01:17

Don

3 years 134 Views

Share Add to Report 0 0

Embed (Iframe):

<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/28708/ideal-patient-to-receive-alimata-plus-keytruda-keynote-189?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Embed (Object):

<div class="embed-responsive embed-responsive-16by9"><object width="640" height="360"><param name="movie" value="https://oncologytube.com/videoEmbed/28708/ideal-patient-to-receive-alimata-plus-keytruda-keynote-189?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit="></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="https://oncologytube.com/videoEmbed/28708/ideal-patient-to-receive-alimata-plus-keytruda-keynote-189?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" allowscriptaccess="always" allowfullscreen="true" width="640" height="360"></embed></object></div>

Link (HTML):

<a href="https://oncologytube.com/v/28708?channelName=obr"><img src="https://oncologytubecom.cdn.ypt.me/videos/video_190701212509_7269/video_190701212509_7269.jpg?cache=15669160871682794628">Ideal Patient to Receive Alimata Plus Keytruda: KEYNOTE-189</a>

Link (BBCode):

[url=https://oncologytube.com/v/28708?channelName=obr][img]https://oncologytubecom.cdn.ypt.me/videos/video_190701212509_7269/video_190701212509_7269.jpg?cache=15669160871682794628[/img]Ideal Patient to Receive Alimata Plus Keytruda: KEYNOTE-189[/url]

Sign in now!

Permanent Link

URL Friendly (SEO)

Current Time (SEO)

Category:

Non-Small Cell Lung Cancer

Description:

Ravi Salgia, MD, Professor and Chair, Department of Medical Oncology and Therapeutics Research, Associate Director for Clinical Sciences, Arthur and Rosalie Kaplan Endowed Chair in Medical Oncology, City of Hope explains the ideal patient to receive Alimta plus Keytrude based on data and results from KEYNOTE-189.